Table 3 Laboratory data associated with gas exchange and coagulation
Variable | Survivors (n = 14) | Non-survivors (n = 6) | p | Patient with hemorrhagic complication (n = 7) | Patient without hemorrhage complications (n = 13) | p |
|---|---|---|---|---|---|---|
Pre-ECLS data | ||||||
PaO2 (mmHg) | 56 (48–73) | 55 (42–67) | 0.55 | 53 (42–66) | 58 (49–69) | 0.59 |
PaO2/FiO2 ratio (mmHg) | 56 (48–73) | 57 (42–68) | 0.66 | 53 (42–66) | 58 (49–70) | 0.7 |
PaCO2 (mmHg) | 61 (47–89) | 52 (41–76) | 0.64 | 49 (40–78) | 52 (49–91) | 1.0 |
Hemoglobin (g/dL) | 11 (10–13) | 9 (8–11) | 0.06 | 10 (9–15) | 11 (9–12) | 0.64 |
Platelet count (×109/L) | 164 (90–193) | 88 (51–34) | 0.11 | 172 (107–183) | 115 (67–193) | 0.76 |
INR of Prothrombin Time > 1.2 | 7 | 6 | 0.05* | 5 | 8 | 1.0 |
aPTT > 35 (seconds) | 7 | 3 | 1.0 | 5 | 5 | 0.35 |
Data collected on ECLS at1 hour | ||||||
PaO2/FiO2 ratio (mmHg) | 108 (65–103) | 103 (71–151) | 0.84 | 99 (166–146) | 110 (74–171) | 0.54 |
PaCO2 (mmHg) | 37 (30–46) | 39 (31–45) | 0.46 | 42 (35–44) | 35 (27–48) | 1.0 |
Hemoglobin g/dL) | 10 (9–11) | 10 (9–14) | 0.72 | 10 (8–12) | 10 (9–11) | 0.76 |
Platelet count (×109/L) | 98 (65–153) | 100 (45–134) | 0.72 | 99 (31–142) | 100 (64–160) | 0.54 |
INR of Prothrombin Time > 12† | 2 | 1 | 1.0 | 3 | 0 | 0.03* |
aPTT > 120† (seconds) | 10 | 6 | 0.27 | 6 | 10 | 1.0 |
at24 hour | ||||||
PaO2/FiO2 ratio (mmHg) | 190 (100–246) | 93 (86–262) | 0.44 | 98 (86–238) | 180 (96–252) | 0.59 |
Hemoglobin (g/dL) | 10 (9–11) | 10 (9–12) | 0.6 | 10 (8.8-12) | 10 (9–11) | 0.82 |
Platelet count (×109/L) | 99 (63–139) | 76 (62–92) | 0.18 | 75 (62–93) | 96 (73–131) | 0.18 |
Before ECLS weaning | ||||||
PaO2/FiO2 ratio (mmHg) | 261 (186–338) | - | - | 229 (135–256) | 288 (178–343) | 0.18 |